Loading…
Beta Bionics, Inc. is projected to rise to $16.39 by 2027, a +41% move from its current price of $11.63. BBNX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $11.18 | $11.64 | $12.12 | +0.10% |
| May 30 | $11.00 | $11.65 | $12.34 | +0.19% |
| May 31 | $10.87 | $11.66 | $12.51 | +0.29% |
| Jun 1 | $10.76 | $11.67 | $12.66 | +0.38% |
| Jun 2 | $10.67 | $11.69 | $12.80 | +0.48% |
| Jun 3 | $10.59 | $11.70 | $12.92 | +0.57% |
| Jun 4 | $10.52 | $11.71 | $13.03 | +0.67% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.52 | $11.71 | $13.03 | +0.67% |
| Week 2 | $10.13 | $11.79 | $13.72 | +1.34% |
| Week 3 | $9.85 | $11.86 | $14.29 | +2.02% |
| Week 4 | $9.64 | $11.94 | $14.81 | +2.70% |
| Week 5 | $9.46 | $12.02 | $15.29 | +3.39% |
| Week 6 | $9.31 | $12.10 | $15.75 | +4.08% |
| Week 7 | $9.17 | $12.19 | $16.19 | +4.78% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Beta Bionics, Inc. is a healthcare company that designs, develops, and commercializes insulin delivery solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.
Beta Bionics, Inc. (BBNX) trades at $11.82, with a market capitalization of $526.72M. It ranks 3005 in market cap rank among listed entities. The 2026 forecast shows an average price of $11.82 with ROI: 0 and sentiment: NEUTRAL.
A major floor 35.8% below — a decisive break under it would weaken the trend.
The nearest floor, 20.9% below — buyers have tended to step in here.
The nearest ceiling, 12.0% above — a clean break opens room to run.
A major ceiling 59.1% above — clearing it would confirm fresh momentum.
Key BBNX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BBNX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.18 | Buy | $11.20 | Buy |
| MA 10 | $10.30 | Buy | $10.73 | Buy |
| MA 20 | $10.20 | Buy | $10.54 | Buy |
| MA 50 | $10.63 | Buy | $11.23 | Buy |
| MA 100 | $13.15 | Sell | $13.48 | Sell |
| MA 200 | $18.74 | Sell | $16.08 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.86 | Neutral |
| Stoch RSI (14) | 91.66 | Sell |
| CCI (20) | 165.57 | Buy |
| Williams %R (14) | -7.25 | Info |
| MACD (12,26,9) | 0.28 | Buy |
| ROC (12) | 20.52 | Buy |
| Bollinger %B (20,2) | 0.98 | Neutral |
| Stochastic %K (14) | 92.75 | Sell |
| TRIX (15) | -0.28 | Sell |
| Awesome (5,34) | 0.48 | Buy |
| Ultimate (7,14,28) | 76.04 | Sell |
| Momentum (10) | 1.81 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 12.13 | Sell |
| ADX (14) | 19.06 | Neutral |
| ATR (14) | 0.37 | Info |
The current 30-day technical picture is sentiment bullish with RSI14 at 60. The stock’s near-term moving averages are SMA50 at $10.59 and SMA200 at $18.77, placing it around a middle ground between recent support and resistance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.86 | $11.63 | $18.92 | 0% | Neutral | |
| $12.21 | $16.39 | $23.69 | +41% | Bullish | |
| $13.31 | $18.74 | $28.56 | +61% | Bullish | |
| $12.60 | $18.47 | $29.34 | +59% | Bullish | |
| $11.79 | $17.92 | $29.47 | +54% | Bullish | |
| $11.62 | $18.28 | $30.98 | +57% | Bullish | |
| $10.60 | $17.20 | $29.95 | +48% | Bullish | |
| $13.70 | $22.94 | $40.91 | +97% | Bullish | |
| $15.98 | $27.55 | $50.23 | +137% | Bullish | |
| $13.83 | $24.54 | $45.66 | +111% | Bullish | |
| $17.51 | $35.58 | $72.01 | +206% | Bullish | |
| $23.96 | $53.25 | $121.49 | +358% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $8.86 | $11.63 | $13.75 | +0.00% |
| June 2026 | $10.22 | $12.16 | $14.94 | +4.57% |
| July 2026 | $10.51 | $12.69 | $15.92 | +4.30% |
| August 2026 | $10.28 | $12.55 | $16.01 | -1.07% |
| September 2026 | $10.61 | $13.06 | $16.88 | +4.09% |
| October 2026 | $11.45 | $14.22 | $18.60 | +8.87% |
| November 2026 | $11.56 | $14.46 | $19.11 | +1.67% |
| December 2026 | $11.25 | $14.17 | $18.92 | -1.97% |
Click any year to see its month-by-month BBNX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Beta Bionics, Inc.'s 2026 outlook centres on $11.63, within a $8.86 to $18.92 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, BBNX could reach as high as $23.69, with a base case around $16.39 and support toward $12.21 — roughly +41% from $11.63. Momentum favours further upside here.
Expect BBNX to range from $13.31 to $28.56 through 2028. The $18.74 average target implies a +61% move from current prices. That is up +14% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The BBNX price prediction for 2029 points to an average of $18.47 (low $12.60, high $29.34) — a potential gain of +59% on today's $11.63. Momentum favours further upside here.
In 2030, BBNX is projected to trade between $11.79 and $29.47, averaging $17.92 — a potential gain of +54% from today's $11.63. That is -3% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
Beta Bionics, Inc.'s 2031 outlook centres on $18.28, within a $11.62 to $30.98 range. That is up +2% on the projected 2030 average. That marks a +57% change versus current levels. Momentum favours further upside here.
By 2032, BBNX could reach as high as $29.95, with a base case around $17.20 and support toward $10.60 — roughly +48% from $11.63. Buyers look set to stay in control over this stretch.
Expect BBNX to range from $13.70 to $40.91 through 2033. The $22.94 average target implies a +97% move from current prices. That is up +33% on the projected 2032 average. Momentum favours further upside here.
The BBNX price prediction for 2034 points to an average of $27.55 (low $15.98, high $50.23) — a potential gain of +137% on today's $11.63. Buyers look set to stay in control over this stretch.
In 2035, BBNX is projected to trade between $13.83 and $45.66, averaging $24.54 — a potential gain of +111% from today's $11.63. That is -11% versus the projected 2034 average. Momentum favours further upside here.
Beta Bionics, Inc.'s 2040 outlook centres on $35.58, within a $17.51 to $72.01 range. That is up +45% on the projected 2035 average. That marks a +206% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, BBNX could reach as high as $121.49, with a base case around $53.25 and support toward $23.96 — roughly +358% from $11.63. Momentum favours further upside here.
Investing $1,000 in BBNX today (≈ 85.984523 BBNX) could be worth
$4,578.75
+$3,578.75 (+358%) by 2050 · US Dollar
Based on the average projected BBNX price of $53.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BBNXwould be worth at today's price.
$1,000 invested in BBNX on May 27, 2025 (≈ 66.889633 BBNX) would be worth
$777.93
-$222.07 (-22.2%) today · 0.78× · US Dollar
Based on a BBNX entry price of $14.95 vs. today's $11.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.11 | $1,150.35 | +15.0% |
| 1 month ago | $10.65 | $1,092.02 | +9.2% |
| 3 months ago | $13.02 | $893.24 | -10.7% |
| 6 months ago | $31.34 | $371.09 | -62.9% |
| 1 year ago | $14.95 | $777.93 | -22.2% |
| All time (1.3y) ago | $23.63 | $492.17 | -50.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BBNX forecast.
Our base-case forecast reaches $23.00 around 2034.
Implied market cap at $23.00: $1.02B
The multi-year forecast paints a bullish path with rising averages and substantial upside. For 2027 the average is projected at $17.26 (ROI: 46) and sentiment remains BULLISH, followed by 2028 at $19.51 (ROI: 65.1) and 2029 at $19.38 (ROI: 64). By 2030 the average is $18.76 (ROI: 58.7) with a continued BULLISH sentiment, and by 2040 the average climbs to $38.12 (ROI: 222.5), then to $56.74 (ROI: 380.1) by 2050.
These figures illustrate a long-run growth scenario, though they are estimates, not guarantees, and depend on future conditions.
Tap a question to reveal the answer.
Avg $18.76; min $12.07; max $31.50; ROI: 58.7; sentiment BULLISH. These are estimates and not guarantees.
Forecasts show bullish sentiment in 2027, 2028, 2029, 2030, 2031, 2032, 2033, 2034, 2035, 2040 and 2050 with rising averages and notable ROI, though 2026 is Neutral with ROI 0. These are estimates, not guarantees.
Forecast max values include $31.50 in 2030, $79.42 in 2040, and $130.51 in 2050. Reaching $50 is possible according to the max projections, but these are not guaranteed.
Current price: $11.82; Market capitalization: $526.72M.
Low $8.89; High $15.71.
Beta Bionics, Inc. Community Discussion
0Share your Beta Bionics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.